Back to trial details

Intake questionnaire

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

Applying to Norton Cancer Institute, Downtown · Louisville, Kentucky

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Small Cell Lung Cancer (SCLC)?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Louisville for study visits?